Task force members charged with creating policy for the state's new stem cell institute say the idea that California may get a portion of profits from new drugs or state residents may get discounts on new therapies, as suggested in Proposition 71 ads, will not happen any time soon, if at all. The task force is wrestling with the question of how to get California taxpayers a return on their money while not hindering investment and research efforts.

Related Summaries